Health ❯ Healthcare ❯ Clinical Trials

Phase 3 Studies

Purpose 2 Study Icotrokinra (JNJ-2113) Eli Lilly Studies Treatment Efficacy Eli Lilly Drug Approval Process OASIS 3 Study Efficacy and Safety LIBERTY-CUPID Program PROTOSTAR Study DREAMM-7 Study Eli Lilly and Company LUNA 3 Study Motor Function Assessment SMA Treatments Weight Loss Medications PALOMA-3 Study AMPLITUDE Study TECVAYLI®

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

Regulatory discussions are planned following independent confirmation of benefit.

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

FDA Clears Tremfya for Children 6 and Older With Plaque Psoriasis and Psoriatic Arthritis

FDA Approves Ionis’ Dawnzera to Prevent Hereditary Angioedema Attacks